Patrys
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAPatrys Limited (PAB) is a therapeutic antibody development company with operations in Australia and the United States of America.
Patrys' expertise and assets target antibody therapeutics in the field of oncology with both IgM antibodies and IgG antibody fragments under development.
Contact Details
Level 4, 100 Albert Road, SOUTH MELBOURNE VIC 3205
03 9692 7222
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1506th | Patrys | -50% | -26% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Patrys | $1.3m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Charmaine Gittleson, Non-Executive Chairman, Non-Executive Director | 07 Aug 2024 |
| NEW ROLE: John Read, Non-Executive Chair | 22 Aug 2022 |
| NEW ROLE: Stefan Ross, Company Secretary | 13 Apr 2022 |
| NEWS: Tagged in Where markets meet medicine; a biotech entrepreneur at the tip of the spear | 14 Feb 2022 |
| NEW ROLE: James Campbell, Chief Executive, Managing Director | 03 Nov 2020 |
| NEW ROLE: Michael Stork, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Suzy Jones, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Pamela Klein, Non-Executive Director | 03 Nov 2020 |
